Contextual reprogramming of CAR-T cells for treatment of HER2+ cancers.
Yang Z, Li L, Turkoz A, Chen P, Harari-Steinfeld R, Bobbin M, Stefanson O, Choi H, Pietrobon V, Alphson B, Goswami A, Balan V, Kearney A, Patel D, Yang J, Inel D, Vinod V, Cesano A, Wang B, Roh KH, Qi LS, Marincola FM. J Transl Med. 2021 Nov 7;19(1):459. doi: 10.1186/s12967-021-03132-6. PMID: 34743703 [PubMed]